BI
BIO icon

Binnacle Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Binnacle Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.96K Hold
7
– – ﹤0.01% 667
2025
Q2 		$1.69K Hold
7
– – ﹤0.01% 603
2025
Q1 		$1.71K Buy
+7
New +$2.11K ﹤0.01% 537

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Binnacle Investments's BIO Position: Q3 2025 in Review

Binnacle Investments held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2025 at 7 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Binnacle Investments first reported a position in BIO in Q1 2025 and has held it in 3 quarters since. 397 funds tracked by Wall St. Rank hold BIO as of Q3 2025.

  • Binnacle Investments held 7 shares of Bio-Rad Laboratories Class A worth $1.96K as of Q3 2025.
  • Binnacle Investments left its Bio-Rad Laboratories Class A share count unchanged in Q3 2025.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #667 holding.
  • Binnacle Investments first reported a position in Bio-Rad Laboratories Class A in Q1 2025 and has held it in 3 quarters since.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.